Saudi Arabia - Re-Export of Heparin for Therapeutic Use
At $173,620.88 in 2016, the country was number 4 comparing other countries in Re-Export of Heparin for Therapeutic Use. Saudi Arabia is overtaken by Barbados, which was number 3 at $212,328.1 and is followed by Jordan at $114,511.44. United States ranked the highest with $4,598,060.57 in 2019, that is -5.2% versus 2018. New Zealand recorded the best 5 years average growth at +141.8% per year, while United States witnessed the worst performance at -29.7% per year.
Loading...
| Date | US Dollars |
|---|---|
| 2016 | 173,620.88 |
| 2015 | 316,178.16 |
| 2014 | 48,559.00 |
| 2013 | |
| 2012 |
Download all data from 1991 to 2016
How does Saudi Arabia rank in Re-Export of Heparin for Therapeutic Use?
| # | 10 Countries | US Dollars | Last | YoY | 5‑years CAGR | |
|---|---|---|---|---|---|---|
| 1 |
#1
United States
|
4,598,060.57 | 2019 | -5.2 % | -29.7 % | View data |
| 2 |
#2
Canada
|
728,579.06 | 2019 | +2.9 % | +13.3 % | View data |
| 3 |
#3
Barbados
|
212,328.10 | 2019 | +12.0 % | +14.6 % | View data |
| 4 |
#4
Saudi Arabia
|
173,620.88 | 2016 | -45.1 % | NA | View data |
| 5 |
#5
Jordan
|
114,511.44 | 2019 | -6.3 % | -22.7 % | View data |